Anson Funds Management LP - 31 Dec 2024 SCHEDULE 13G Report for Oncolytics Biotech, Inc. Common Stock, no par value (ONCY)

Filing Manager
Anson Funds Management LP
Reporting Manager
Anson Funds Management LP
Security
Oncolytics Biotech, Inc. Common Stock, no par value
Symbol
ONCY
Shares outstanding
85,268,156 shares
Disclosed Ownership
8,185,743 shares
Ownership
9.6%
Form type
SCHEDULE 13G
Filing time
14 Feb 2025, 18:30:40 UTC
Date of event
31 Dec 2024
Next filing
14 Nov 2025
SEC
View on sec.gov

Reporting Managers (6)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Anson Funds Management LP 9.6% 8,185,743 0 8,185,743 /s/ Tony Moore Tony Moore, Manager
Anson Management GP LLC 9.6% 8,185,743 0 8,185,743 /s/ Tony Moore Tony Moore, Manager
Tony Moore 9.6% 8,185,743 0 8,185,743 /s/ Tony Moore Tony Moore
Anson Advisors Inc. 9.6% 8,185,743 0 8,185,743 /s/ Amin Nathoo Amin Nathoo Director
Amin Nathoo 9.6% 8,185,743 0 8,185,743 /s/ Amin Nathoo Amin Nathoo
Moez Kassam 9.6% 8,185,743 0 8,185,743 /s/ Moez Kassam Moez Kassam, Director